Correlation Between Fluoguide and Scandion Oncology
Can any of the company-specific risk be diversified away by investing in both Fluoguide and Scandion Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fluoguide and Scandion Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fluoguide AS and Scandion Oncology AS, you can compare the effects of market volatilities on Fluoguide and Scandion Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fluoguide with a short position of Scandion Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fluoguide and Scandion Oncology.
Diversification Opportunities for Fluoguide and Scandion Oncology
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Fluoguide and Scandion is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Fluoguide AS and Scandion Oncology AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scandion Oncology and Fluoguide is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fluoguide AS are associated (or correlated) with Scandion Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scandion Oncology has no effect on the direction of Fluoguide i.e., Fluoguide and Scandion Oncology go up and down completely randomly.
Pair Corralation between Fluoguide and Scandion Oncology
Assuming the 90 days trading horizon Fluoguide AS is expected to generate 2.52 times more return on investment than Scandion Oncology. However, Fluoguide is 2.52 times more volatile than Scandion Oncology AS. It trades about 0.3 of its potential returns per unit of risk. Scandion Oncology AS is currently generating about -0.22 per unit of risk. If you would invest 3,550 in Fluoguide AS on October 23, 2024 and sell it today you would earn a total of 1,390 from holding Fluoguide AS or generate 39.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 93.75% |
| Values | Daily Returns |
Fluoguide AS vs. Scandion Oncology AS
Performance |
| Timeline |
| Fluoguide AS |
| Scandion Oncology |
Fluoguide and Scandion Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fluoguide and Scandion Oncology
The main advantage of trading using opposite Fluoguide and Scandion Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fluoguide position performs unexpectedly, Scandion Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scandion Oncology will offset losses from the drop in Scandion Oncology's long position.| Fluoguide vs. ExpreS2ion Biotech Holding | Fluoguide vs. Hansa Biopharma AB | Fluoguide vs. cBrain AS | Fluoguide vs. BioPorto |
| Scandion Oncology vs. ExpreS2ion Biotech Holding | Scandion Oncology vs. Hansa Biopharma AB | Scandion Oncology vs. Fluoguide AS | Scandion Oncology vs. Saniona AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |